A Randomized, Phase 1B, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2017
At a glance
- Drugs PUR 003 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Pulmatrix
- 03 May 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 03 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.